Delivery Order SPE2DR25D2014-SPE2DR26FA0X3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,704.30 on November 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures, with an ultimate completion date of November 19, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $30,199.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure, with an ultimate completion date of November 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $6,518.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order executed under an existing contract vehicle and requires fulfillment within an...
- The Defense Logistics Agency awarded a delivery order valued at $7,758.90 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injectors on December 12, 2025, with an ultimate completion date of December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply for military healthcare needs. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $17,498.32 delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on November 24, 2025, with a completion date of November 25, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded delivery order for a diabetes medication to support federal medical procurement needs. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $27,216.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of September 22, 2025. This non-set-aside delivery order was competitively awarded and represents a single transaction under AmerisourceBergen's existing contract vehicles supporting federal pharmaceutical procurement. The product will be delivered to the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $12,150.18 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on November 17, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of November 18, 2025. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,564.89 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-competitive, firm fixed-price delivery order was executed without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $7,135.59 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections valued at $9,805.19 on May 30, 2025, with completion scheduled for June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0X3Delivery Order
The Defense Logistics Agency awarded a $12,054.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections, with a completion date of December 30, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply needs for federal healthcare programs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support across multiple therapeutic domains, enabling the contractor to supply specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. The delivery order reflects the contractor's established capability to meet federal procurement requirements and supply critical medications including diabetes treatments to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 12/28/25 |